Craig Miller

Craig Miller is a highly experienced scientist at Boehringer Ingelheim, currently serving as Senior Principal Scientist and Research Project Leader since December 2008. With a strong background in drug discovery, Craig has led multidisciplinary teams to identify and advance novel small molecule therapies into clinical development, contributing significantly to the Medicinal Chemistry Department's leadership with strategic responsibilities. Prior to this role, Craig was the Research Laboratory Head, guiding efforts to develop small molecule inhibitors for cancer treatment. Craig’s career at Boehringer Ingelheim began in December 2003 as a Senior Scientist and Laboratory Head. Academically, Craig holds a Master's degree in Organic Chemistry from the University of Toronto and a Bachelor of Science from Queen's University, both establishing a solid foundation in the field.